C. Gerardi

发表

Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients

P. Cianciulli, L. Cuccia, G. D'Ascola, 2012, American journal of hematology.

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.

P. Cianciulli, R. Barone, L. Cuccia, 2013, Blood cells, molecules & diseases.

Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron

V. Positano, A. Meloni, P. Preziosi, 2018, European Radiology.

Multicentre study on prevalence of endocrine complications in thalassaemia major

S. Andò, M. Cisternino, G. D'Ascola, 1995, Clinical endocrinology.

Relationship between uric acid levels and cardiometabolic findings in a large cohort of β-thalassemia major patients.

V. Positano, A. Meloni, C. Vassalle, 2018, Biomarkers in medicine.

IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection

M. Levrero, F. Bronte, A. Craxì, 2012, Haematologica.

Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial

G. D’Amico, A. Morabito, C. Gluud, 2009, British journal of haematology.

Feasibility, Reproducibility and Reliability for the T2* Iron Evaluation At 3T in Comparison with 1.5T

V. Positano, M. Lombardi, A. Meloni, 2011 .

Potential Myocardial Iron Content Evaluation by Magnetic Resonance Imaging in Thalassemia Major Patients Treated with Deferoxamine or Deferiprone During a Randomized Multicenter Prospective Clinical Study

A. Morabito, M. Galia, M. Midiri, 2003, Hemoglobin.

Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T

V. Positano, M. Lombardi, A. Meloni, 2012, Magnetic resonance in medicine.

Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study

V. Positano, M. Lombardi, L. Gulino, 2013, British journal of haematology.

Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients

G. D’Amico, A. Morabito, C. Gluud, 2011, Hemoglobin.

alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.

A. Maggio, D. Renda, V. Di Marco, 1992, Haematologica.

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

L. Cuccia, V. Caruso, A. Filosa, 2017, British journal of haematology.

Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia.

A. Maggio, D. Renda, V. Di Marco, 1993, Gut.

Real‐life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET

B. Giorgi, G. Abbate, V. Caruso, 2016, European journal of haematology.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

P. Cianciulli, L. Cuccia, V. Caruso, 2009, Blood cells, molecules & diseases.

Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β‐thalassemia: results from a preliminary study

M. Napolitano, S. Siragusa, C. Gerardi, 2016, Transfusion.

HCV clearance among hemophiliacs and beta-thalassemics.

F. Bronte, A. Maggio, V. Di Marco, 2007, Gastroenterology.

Longitudinal follow‐up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study

V. Positano, A. Meloni, M. Midiri, 2020, British journal of haematology.

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial

L. Pitrolo, A. Maggio, R. Di Maggio, 2015, American journal of hematology.

Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients

V. Positano, A. Meloni, A. Pepe, 2015, American journal of hematology.

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major

Filippo Cademartiri, V. Positano, A. Meloni, 2023, Diagnostics.

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET

D. Fiorino, A. Filosa, L. Pitrolo, 2018, European journal of haematology.

Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients

Filippo Cademartiri, V. Positano, S. Bagnato, 2022, Annals of Hematology.

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

G. D’Amico, A. Morabito, P. Cianciulli, 2007 .

Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death.

N. Chattipakorn, A. Phrommintikul, P. Cianciulli, 2013, Blood cells, molecules & diseases.

Influence of myocardial fibrosis and blood oxygenation on heart T2* values in thalassemia patients

V. Positano, M. Santarelli, L. Landini, 2009, Journal of magnetic resonance imaging : JMRI.

Fast generation of T2⁎ maps in the entire range of clinical interest: Application to thalassemia major patients

Luigi Landini, Vincenzo Positano, Maria Filomena Santarelli, 2015, Comput. Biol. Medicine.

Right Ventricular Volumes and Function normalized to body surface area, age and sex in a large cohort of well-treated Thalassemia Major without myocardial iron overload

V. Positano, G. Aquaro, M. Lombardi, 2011, Journal of Cardiovascular Magnetic Resonance.

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance

A. Meloni, A. Cossu, E. Grassedonio, 2023, Journal of clinical medicine.

Left atrial strain in patients with β-thalassemia major: a cross-sectional CMR study.

V. Positano, A. Meloni, M. Porcu, 2024, European radiology.